Stein, J. D., Newman-Casey, P. A., Mrinalini, T., Lee, P. P., & Hutton, D. W. (2014). Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration.

Stein, Joshua D., Paula Anne Newman-Casey, Tavag Mrinalini, Paul P. Lee, und David W. Hutton. Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration. 2014.

Stein, Joshua D., et al. Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration. 2014.